FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Immunization

75,411 resources

Type: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 11200 - 11400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuth
smart.who.int.hivR4Measure/HIVIND32HIV.IND.32 Viral load testing coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND34HIV.IND.34 Appropriate second viral load test after adherence counsellingdraft2024-08who
smart.who.int.hivR4Measure/HIVIND71HIV.IND.71 Gonorrhoea testing coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND75HIV.IND.75 Gonorrhoea treatment coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND67HIV.IND.67 Syphilis treatment coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND31HIV.IND.31 Late ART initiationdraft2024-08who
smart.who.int.hivR4Measure/HIVIND73HIV.IND.73 Gonorrhoea test positivity, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND84HIV.IND.84 HCV test coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND81HIV.IND.81 HBV test coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND63HIV.IND.63 Syphilis test positivity, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND59HIV.IND.59 Syphilis testing coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND46HIV.IND.46 TB diagnostic testing typedraft2024-08who
smart.who.int.hivR4Measure/HIVIND89HIV.IND.89 HCV positivity, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND21HIV.IND.21 Linkage to ARTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND54HIV.IND.54 Uptake of DSD ART models among people living with HIVdraft2024-08who
smart.who.int.hivR4Measure/HIVIND3HIV.IND.3 PrEP coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND56HIV.IND.56 Retention in DSD ART modelsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND25HIV.IND.25 HIV retesting coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND9HIV.IND.9 Regular NSP accessdraft2024-08who
smart.who.int.hivR4Measure/HIVIND8HIV.IND.8 NSP coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND72HIV.IND.72 Gonorrhoea test positivity, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND12HIV.IND.12 Total person-years on OAMTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND68HIV.IND.68 Syphilis treatment coverage, pregnant women, first ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND43HIV.IND.43 HIV prevalence among women attending ANCdraft2024-08who
smart.who.int.hivR4Measure/HIVIND64HIV.IND.64 Syphilis test positivity, pregnant women, first visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND65HIV.IND.65 Syphilis test positivity, pregnant women, any visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND69HIV.IND.69 Syphilis treatment coverage, pregnant women, any ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND82HIV.IND.82 HBV test coverage, pregnant womendraft2024-08who
smart.who.int.hivR4Measure/HIVIND61HIV.IND.61 Syphilis testing coverage, pregnant women, any ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND60HIV.IND.60 Syphilis testing coverage, pregnant women, first ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND95HIV.IND.95 Invasive cervical cancer treatmentdraft2024-08who
smart.who.int.hivR4Measure/HIVIND94HIV.IND.94 Pre-invasive cervical disease treatmentdraft2024-08who
smart.who.int.hivR4Measure/HIVIND20HIV.IND.20 Individuals testing positive for HIVdraft2024-08who
hl7.fhir.us.davinci-deqmR4Measure/measure-mrp-exampleMRP Measureactive2019-12ushl7
hl7.fhir.uv.cqmR4Measure/measure-cqm-publishable-exampleMeasure CQM Publishable Exampleactive2025-07uvhl7
hl7.fhir.uv.cqmR4Measure/age-stratified-exampleMeasure Age Stratified Exampleactive2025-08uvhl7
smart.who.int.hivR4Measure/HIVIND24HIV.IND.24 HTS linkage to preventiondraft2024-08who
hl7.fhir.uv.cqmR4Measure/measure-pi-exmEXM Promoting Interoperability Measureactive2023-05uvhl7
hl7.fhir.uv.cqmR4Measure/EXMLogic-FHIREXM Measureactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/EXMLogic-FHIREXM Measureactive2022-02ushl7
hl7.fhir.uv.cqmR4Measure/EXMRatio-FHIREXM Ratio Measureactive2025-08uvhl7
hl7.fhir.uv.cqmR4Measure/measure-publishable-exmEXM Publishable Measureactivecqi2025-08uvhl7
hl7.fhir.us.davinci-deqmR4Measure/measure-pi-exampleEXM Promoting Interoperability Measureactive2023-05ushl7
hl7.fhir.uv.cpgR4Measure/chf-bodyweight-change-measureCHF Body Weight Change Metricactive2024-11uvhl7
hl7.fhir.uv.cpgR4Measure/chf-bodyweight-measureCHF Body Weight Metricactive2024-11uvhl7
smart.who.int.hivR4Measure/HIVIND96HIV.IND.96 Cervical cancer survivaldraft2024-08who
example.fhir.uv.mycontentigR4Measure/HRExampleCVMeasureHR Example CV (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
example.fhir.uv.mycontentigR4Measure/HRExampleCohortMeasureHR Example Cohort (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
example.fhir.uv.mycontentigR4Measure/HRExampleProportionMeasureHR Example Proportion (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
example.fhir.uv.mycontentigR4Measure/HRExampleRatioMeasureHR Example Ratio (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
hl7.fhir.us.davinci-vbprR4Measure/vbp-measure02Example Value-Based Contract - ABC Payer and EveryHospitalactive2025-07ushl7
hl7.fhir.us.davinci-vbprR4Measure/vbp-measure01Example Value-Based Contract - ABC Payer and GoodHealthactive2025-07ushl7
hl7.fhir.uv.cpgR4Measure/activity-example-generatereport-measureActivity Example Generate Report Measureactive2023-10uvhl7
example.fhir.uv.mycontentigR4Measure/QuestionnaireMeasureExampleQuestionnaire Measure Exampledraft2025-08uvhl7
hl7.fhir.us.davinci-raR4Measure/RAModelExample02Risk Adjustment Model Version 21 - CMS Hierarchical Category Condition (CMS-HCC)active2021-09ushl7
hl7.fhir.us.davinci-raR4Measure/RAModelExample01Risk Adjustment Model Version 24 - CMS Hierarchical Category Condition (CMS-HCC)active2021-08ushl7
hl7.fhir.us.davinci-raR4Measure/RAModelExample03Risk Adjustment Model Version 5 - CMS Prescribing Drug Hierarchical Category Condition (CMS-RxHCC)active2021-09ushl7
hl7.fhir.us.safrR4Measure/HospitalRespiratoryDataMeasureMeasure - HRD Measure Exampledraft2024-12ushl7
ihe.qrph.madxR4Measure/madx-hiv-indicator-example1mADX-Measure-example1draft2024-08uvihe
ihe.qrph.madxR4Measure/madx-hiv-indicator-example2mADX-Measure-example2draft2024-08uvihe
smart.who.int.immunizationsR4Measure/IMMZIND01IMMZIND01draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND02IMMZIND02draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND03IMMZIND03draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND04IMMZIND04draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND05IMMZIND05draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND06IMMZIND06draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND07IMMZIND07draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND08IMMZIND08draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND09IMMZIND09draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND10IMMZIND10draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND11IMMZIND11draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND12IMMZIND12draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND13IMMZIND13draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND14IMMZIND14draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND15IMMZIND15draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND16IMMZIND16draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND17IMMZIND17draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND18IMMZIND18draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND19IMMZIND19draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND20IMMZIND20draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND21IMMZIND21draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND22IMMZIND22draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND23IMMZIND23draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND24IMMZIND24draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND25IMMZIND25draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND26IMMZIND26draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND27IMMZIND27draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND28IMMZIND28draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND29IMMZIND29draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND30IMMZIND30draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND31IMMZIND31draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND32IMMZIND32draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND33IMMZIND33draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND34IMMZIND34draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND35IMMZIND35draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND36IMMZIND36draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND37IMMZIND37draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND38IMMZIND38draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND39IMMZIND39draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND44IMMZIND44draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND45IMMZIND45draft2025-06who
gov.healthit.ecqi.ecqmsR4Measure/CMS72FHIRSTKAntithromboticDay2Antithrombotic Therapy By End of Hospital Day 2FHIRactive2025-07
example.fhir.uv.mycontentigR4Measure/DischargedonAntithromboticTherapyFHIRExampleDischarged on Antithrombotic Therapy FHIR Exampledraft2025-08uvhl7
gov.healthit.ecqi.ecqms.subsetR4Measure/DischargedonAntithromboticTherapyFHIRDischarged on Antithrombotic TherapyFHIRactive2024-09
gov.healthit.ecqi.ecqmsR4Measure/CMS104FHIRSTKDCAntithromboticDischarged on Antithrombotic TherapyFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS71FHIRSTKAnticoagAFFlutterAnticoagulation Therapy for Atrial Fibrillation/FlutterFHIRactive2025-07
hl7.fhir.us.pcoR4Measure/GoalIdentificationMeasurePerson-Centered Goal Identificationdraftpc2025-02ushl7
hl7.fhir.us.pcoR4Measure/GoalFollowUpMeasurePerson-Centered Goal Follow-Updraftpc2025-02ushl7
hl7.fhir.us.davinci-deqmR4Measure/attestation-boolean-exampleImmunization Registry Reportingactivecqi2025-07ushl7
hl7.fhir.us.mihrR4Measure/PIHCohortPIH Cohortdraft2022-11ushl7
hl7.fhir.us.mihrR4Measure/PAMDeathsPAMDeaths Cohortdraft2022-11ushl7
gov.healthit.ecqi.ecqmsR4Measure/CMS0334FHIRPCCesareanBirthCesarean BirthFHIRactive2025-07
smart.who.int.hivR4Measure/HIVIND44HIV.IND.44 TPT initiationdraft2024-08who
smart.who.int.hivR4Measure/HIVIND28HIV.IND.28 Total attrition from ARTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND45HIV.IND.45 TPT completiondraft2024-08who
smart.who.int.hivR4Measure/HIVIND33HIV.IND.33 Early viral load testing (at six months)draft2024-08who
smart.who.int.hivR4Measure/HIVIND18HIV.IND.18 People living with HIV who know their HIV status (first 95)draft2024-08who
smart.who.int.hivR4Measure/HIVIND27HIV.IND.27 People living with HIV on ARTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND19HIV.IND.19 HTS test volume and positivitydraft2024-08who
smart.who.int.hivR4Measure/HIVIND30HIV.IND.30 New ART patientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND5HIV.IND.5 Number of PEP recipientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND2HIV.IND.2 Total PrEP recipientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND22HIV.IND.22 HTS partner servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND93HIV.IND.93 Cervical cancer screeningdraft2024-08who
gov.healthit.ecqi.ecqms.subsetR4Measure/SevereObstetricComplicationsFHIRSevere Obstetric ComplicationsFHIRactive2024-09
gov.healthit.ecqi.ecqmsR4Measure/CMS1028FHIRPCSevereOBCompsSevere Obstetric ComplicationsFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS130FHIRColorectalCancerScreeningColorectal Cancer ScreeningFHIRactive2025-06
hl7.fhir.uv.cqmR4Measure/EXM130-FHIREXM130 - Colorectal Cancer Screening Measureactive2025-08uvhl7
fhir.cqf.cccR4Measure/ColorectalCancerScreeningCQMColorectal Cancer Screening CQMdraft2025-06ushl7
hl7.fhir.us.cqfmeasuresR4Measure/EXM130-FHIREXM130 - Colorectal Cancer Screening Measureactive2022-02ushl7
gov.healthit.ecqi.ecqmsR4Measure/CMS133FHIRCataracts2040BCVAwithin90DaysCataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract SurgeryFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS117FHIRChildhoodImmunizationStatusChildhood Immunization StatusFHIRactive2025-07
hl7.fhir.uv.cqmR4Measure/EXM146-FHIREXM146 - Appropriate Testing for Children with Pharyngitisactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/EXM146-FHIREXM146 - Appropriate Testing for Children with Pharyngitisactive2022-02ushl7
gov.healthit.ecqi.ecqmsR4Measure/CMS75FHIRChildrenWhoHaveDentalDecayOrCavitiesChildren Who Have Dental Decay or CavitiesFHIRactive2025-07
gov.healthit.ecqi.ecqms.subsetR4Measure/PrimaryCariesPreventionasOfferedbyDentistsFHIRPrimary Caries Prevention Intervention as Offered by DentistsFHIRactive2024-09
gov.healthit.ecqi.ecqmsR4Measure/CMS74FHIRPrimaryCariesPreventionasOfferedbyDentistsPrimary Caries Prevention Intervention as Offered by DentistsFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS996FHIRAptTxforSTEMIAppropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department FHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS22FHIRPCSBPScreeningFollowUpPreventive Care and Screening: Screening for High Blood Pressure and Follow-Up DocumentedFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/OncologyPainIntensityQuantifiedFHIROncology: Medical and Radiation Pain Intensity QuantifiedFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS128FHIRAntidepressantMedManagementAntidepressant Medication ManagementFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS122FHIRDiabetesAssessGreaterThan9PercentDiabetes: Glycemic Status Assessment Greater Than 9%FHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS165FHIRControllingHighBloodPressureControlling High Blood PressureFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS56FHIRFunctionalStatusAssessmentforTotalHipReplacementFunctional Status Assessment for Total Hip ReplacementFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS155FHIRWeightAssessandCounselforKidsWeight Assessment and Counseling for Nutrition and Physical Activity for Children/AdolescentsFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS2FHIRPCSDepressionScreenAndFollowUpPreventive Care and Screening: Screening for Depression and Follow-Up PlanFHIRactive2025-06
gov.healthit.ecqi.ecqms.subsetR4Measure/HIVScreeningFHIRHIV ScreeningFHIRactive2024-09
gov.healthit.ecqi.ecqmsR4Measure/CMS349FHIRHIVScreeningHIV ScreeningFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS69FHIRPCSBMIScreenAndFollowUpPreventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up PlanFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS145FHIRCADBetaBlockerTherapyPriorMIorLVSDCoronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)FHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS142FHIRDRCommunicationWithPhysicianManagingDiabetesDiabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes CareFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS144FHIRHFBetaBlockerTherapyforLVSDHeart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS135FHIRHFACEIorARBorARNIforLVSDHeart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS143FHIRPOAGOpticNerveEvaluationPrimary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS645FHIRBoneDensityProstateCancerAndrogenDeprivationTherapyBone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation TherapyFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancerIntravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder CancerFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS771FHIRUrinarySymptomScoreChangeBenignProstaticHyperplasiaUrinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic HyperplasiaFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS50FHIRCRLReceiptofSpecialistReportClosing the Referral Loop: Receipt of Specialist ReportFHIRactive2025-07
example.fhir.uv.mycontentigR4Measure/HIVViralSuppressionFHIRExampleHIV Viral Suppression FHIR Exampledraft2025-08uvhl7
gov.healthit.ecqi.ecqmsR4Measure/CMS149FHIRDementiaCognitiveAssessmentDementia: Cognitive AssessmentFHIRactive2025-07
smart.who.int.hivR4Measure/HIVIND85HIV.IND.85 HBsAg positivity, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND86HIV.IND.86 HBsAg positivity, HIV-positive clientsdraft2024-08who
smart.who.int.ancR4Measure/ANCIND12ANC.IND.12 Percentage of pregnant women counselled and tested for HIVdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND03ANC.IND.03 Percentage of pregnant women screened for syphilis during ANCdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND02ANC.IND.02 Percentage of pregnant women who received iron and folic acid (IFA) supplements for 90+ daysdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND13ANC.IND.13 Percentage of pregnant women who received oral pre-exposure prophylaxis (PrEP)draft2025-06uvwho
smart.who.int.hivR4Measure/HIVIND87HIV.IND.87 HBsAg positivity, pregnant womendraft2024-08who
smart.who.int.ancR4Measure/ANCIND05ANC.IND.05 Percentage of pregnant women with a minimum of eight antenatal care contactsdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND10ANC.IND.10 Percentage of pregnant women with an ultrasound scan before 24 weeksdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND04ANC.IND.04 Percentage of pregnant women with at least four ANC contactsdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND07ANC.IND.07 Percentage of pregnant women with at least one blood pressure measure during ANCdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND08ANC.IND.08 Percentage of pregnant women with at least one blood pressure measure in the third trimester during ANCdraft2025-06uvwho
hl7.fhir.uv.crmiR4Measure/publishable-exampleANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester (Publishable Example)draft2023-03uvhl7
hl7.fhir.uv.crmiR4Measure/shareable-exampleANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester (Shareable Example)draft2023-03uvhl7
smart.who.int.ancR4Measure/ANCIND01ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimesterdraft2025-06uvwho
gov.healthit.ecqi.ecqmsR4Measure/CMS68FHIRDocumentationofCurrentMedicationsDocumentation of Current Medications in the Medical RecordFHIRactive2025-07
hl7.fhir.uv.cqmR4Measure/EXM124-FHIREXM124 - Cervical Cancer Screeningactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/EXM124-FHIREXM124 - Cervical Cancer Screeningactive2022-02ushl7
gov.healthit.ecqi.ecqmsR4Measure/CMS124FHIRCervicalCancerScreeningCervical Cancer ScreeningFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS125FHIRBreastCancerScreeningBreast Cancer ScreeningFHIRactive2025-06
hl7.fhir.uv.cqmR4Measure/EXM125-FHIREXM125 - Breast Cancer Screeningactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/EXM125-FHIREXM125 - Breast Cancer Screeningactive2022-02ushl7
smart.who.int.ancR4Measure/ANCIND11ANC.IND.11 Percentage of women who received three doses or more of intermittent preventive therapy for malaria (IPTp) during their last pregnancydraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND09ANC.IND.09 Percentage of pregnant women whose baby’s heartbeat was listened to at least once during ANCdraft2025-06uvwho
smart.who.int.ancR4Measure/ANCIND06ANC.IND.06 Pregnant women who received counselling on danger signs (%) during at least one ANC contactdraft2025-06uvwho
gov.healthit.ecqi.ecqmsR4Measure/CMS506FHIRSafeUseofOpioidsSafe Use of Opioids - Concurrent PrescribingFHIRactive2025-07
hl7.fhir.uv.sanerR4Measure/CDCHealthcareSupplyPathwayCOVID-19 Healthcare Supply Pathwaydraft2020-04uvhl7
hl7.fhir.uv.sanerR4Measure/CDCHealthcareWorkerStaffingPathwayCOVID-19 Healthcare Worker Staffing Pathwaydraft2020-04uvhl7
hl7.fhir.us.nhsn-dqmR4Measure/NHSNdQMAcuteCareHospitalInitialPopulationNHSN dQM Acute Care Hospital Initial Populationdraft2024-02ushl7
gov.healthit.ecqi.ecqmsR4Measure/CMS832HHAKIFHIRHospital Harm - Acute Kidney InjuryFHIRactive2025-05
gov.healthit.ecqi.ecqmsR4Measure/CMS816FHIRHHHypoHospital Harm - Severe HypoglycemiaFHIRactive2025-06
gov.healthit.ecqi.ecqmsR4Measure/CMS826FHIRHHPIHospital Harm - Pressure InjuryFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS159FHIRDepressionRemissionatTwelveMonthsDepression Remission at Twelve MonthsFHIRactive2025-07
gov.healthit.ecqi.ecqmsR4Measure/CMS146FHIRAppropriateTestingforPharyngitisAppropriate Testing for PharyngitisFHIRactive2025-06
hl7.fhir.uv.cqmR4Measure/PreventiveCareandWellnessPatientLevelLinearCompositePreventive Care and Wellness Patient-level Linear Compositeactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/PreventiveCareandWellnessPatientLevelLinearCompositePreventive Care and Wellness Patient-level Linear Compositedraft2024-11ushl7
hl7.fhir.uv.cqmR4Measure/PreventiveCareandWellnessWeightedCompositePreventive Care and Wellness Weighted Compositeactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/PreventiveCareandWellnessWeightedCompositePreventive Care and Wellness Weighted Compositedraft2024-11ushl7
hl7.fhir.uv.cqmR4Measure/PreventiveCareandWellnessAllOrNothingCompositePreventive Care and Wellness All-Or-Nothing Compositeactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/PreventiveCareandWellnessAllOrNothingCompositePreventive Care and Wellness All-Or-Nothing Compositedraft2024-11ushl7